810 reports of this reaction
4.2% of all SEVELAMER CARBONATE reports
#4 most reported adverse reaction
NAUSEA is the #4 most commonly reported adverse reaction for SEVELAMER CARBONATE, manufactured by Genzyme Corporation. There are 810 FDA adverse event reports linking SEVELAMER CARBONATE to NAUSEA. This represents approximately 4.2% of all 19,097 adverse event reports for this drug.
Patients taking SEVELAMER CARBONATE who experience nausea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
NAUSEA is moderately reported among SEVELAMER CARBONATE users, representing a notable but not dominant share of adverse events.
In addition to nausea, the following adverse reactions have been reported for SEVELAMER CARBONATE:
The following drugs have also been linked to nausea in FDA adverse event reports:
NAUSEA has been reported as an adverse event in 810 FDA reports for SEVELAMER CARBONATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
NAUSEA accounts for approximately 4.2% of all adverse event reports for SEVELAMER CARBONATE, making it a notable side effect.
If you experience nausea while taking SEVELAMER CARBONATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.